Doctor Kristian Berge

Doctor Kristian Berge

Akershus University Hospital - AHUS, Nordbyhagen (Norway)

Member of:

Dr. Berge is a cardiology fellow and postdoctoral researcher at Akershus University Hospital, Norway, with a primary research focus on heart failure, cardiac biomarkers, and sports cardiology. His current postdoctoral project addresses implementation and adherence to guideline-directed medical therapy in heart failure, using data from the Norwegian Heart Failure Registry.

Presentations Articles

Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF Guidelines: a nationwide registry study

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Latest registries and observational studies

Access

Reasons for underutilization of medical therapy for heart failure with reduced ejection fraction

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: ePosters in chronic heart failure - pharmacotherapy (4)

Access

Utilization and safety of digoxin in patients with chronic heart failure and atrial fibrillation with rapid ventricular rate

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Drug therapy for heart failure: what is new?

Access

Heart failure in elderly patients with a recent myocardial infarction and the effect of omega-3 fatty acids: secondary analysis from the OMEMI trial

Event: Heart Failure 2024

Topic: Treatment

Session: Chronic heart failure - treatment 1

Access

Predictors of coronary atherosclerosis in middle-aged and older endurance athletes

Event: ESC Congress 2023

Topic: Pathophysiology and Mechanisms

Session: Coronary artery disease: lifestyle and environmental factors

Access

National Early Warning Score 2 provides independent prognostic information in patients hospitalized with heart failure with preserved ejection fraction

Event: ESC Congress 2022

Topic: Diagnostic Methods

Session: Chronic heart failure - Prognosis and prediction of outcome

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Kristian Berge

Biography

Contributor content

Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF Guidelines: a nationwide registry study

Reasons for underutilization of medical therapy for heart failure with reduced ejection fraction

Utilization and safety of digoxin in patients with chronic heart failure and atrial fibrillation with rapid ventricular rate

Heart failure in elderly patients with a recent myocardial infarction and the effect of omega-3 fatty acids: secondary analysis from the OMEMI trial

Predictors of coronary atherosclerosis in middle-aged and older endurance athletes

National Early Warning Score 2 provides independent prognostic information in patients hospitalized with heart failure with preserved ejection fraction

ESC 365 is supported by

Doctor Kristian Berge Follow

Biography

Contributor content

Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF Guidelines: a nationwide registry study

Reasons for underutilization of medical therapy for heart failure with reduced ejection fraction

Utilization and safety of digoxin in patients with chronic heart failure and atrial fibrillation with rapid ventricular rate

Heart failure in elderly patients with a recent myocardial infarction and the effect of omega-3 fatty acids: secondary analysis from the OMEMI trial

Predictors of coronary atherosclerosis in middle-aged and older endurance athletes

National Early Warning Score 2 provides independent prognostic information in patients hospitalized with heart failure with preserved ejection fraction

ESC 365 is supported by

Doctor Kristian Berge